EREG and cancer: Combining NPG with HO-1 inhibitor demonstrated down-regulation of genes involved in cancer cell invasion and proliferation (EGR1, CXCL2, AREG, CXCL3, EREG, CD3e, CD3g, CD74, and B2M) as compared to NPG or to control animals (Figure 8C).